Both CD34+38+ and CD34+38- cells home specifically to the bone marrow of NOD/LtSZ scid/scid mice but show different kinetics in expansion

被引:58
作者
Kerre, TCC
De Smet, G
De Smedt, M
Offner, F
De Bosscher, J
Plum, J
Vandekerckhove, B
机构
[1] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Hematol, B-9000 Ghent, Belgium
[3] Bloedtransfusiecentrum Oost Vlaanderen, Ghent, Belgium
关键词
D O I
10.4049/jimmunol.167.7.3692
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human hemopoietic stem cells (HSC) have been shown to engraft, differentiate, and proliferate in the hemopoietic tissues of sublethally irradiated NOD/LtSZ scid/scid (NOD/SCID) mice. We used this model to study homing, survival, and expansion of human HSC populations from different sources or phenotype. We observed that CD34(+) cells homed specifically to bone marrow (BM) and spleen, but by 3 days after injection, survived only in the BM. These BM-homed CD34(+) cells proliferated intensively and gave rise to a 12-fold, 5.5-fold, and 4-fold expansion in 3 days for umbilical cord blood, adult mobilized peripheral blood, and adult BM-derived cells, respectively. By injection of purified subpopulations, it was demonstrated that both CD34(+)38(+) and CD34(+)38(-) umbilical cord blood HSC homed to the BM and expanded. Importantly, kinetics of expansion were different: CD34(+)38(+) cells started to increase in cell number from day 3 onwards, and by 4 wk after injection, virtually all CD34(+) cells had disappeared. In contrast, CD34(+)38(-) cells remained quiescent during the first week and started to expand intensively from the third week on. In this paper, we have shown that homing, survival, and expansion of stem cells are three independent phenomena important in the early phase of BM engraftment and that kinetics of engraftment differ between CD34(+)38(+) and CD34(+)38(-) cells.
引用
收藏
页码:3692 / 3698
页数:7
相关论文
共 48 条
[1]  
Belvedere O, 1999, BLOOD CELL MOL DIS, V25, P140
[2]  
Bensinger W, 1999, BLOOD, V94, p368A
[3]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[4]   Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice [J].
Bhatia, M ;
Wang, JCY ;
Kapp, U ;
Bonnet, D ;
Dick, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5320-5325
[5]   Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle [J].
Blaise, D ;
Kuentz, M ;
Fortanier, C ;
Bourhis, JH ;
Milpied, N ;
Sutton, L ;
Jouet, JP ;
Attal, M ;
Bordigoni, P ;
Cahn, JY ;
Boiron, JM ;
Schuller, MP ;
Moatti, JP ;
Michalle, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :537-546
[6]   Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood [J].
Cashman, J ;
Bockhold, K ;
Hogge, DE ;
Eaves, AC ;
Eaves, CJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :1026-1036
[7]   Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice [J].
Cashman, JD ;
Lapidot, T ;
Wang, JCY ;
Doedens, M ;
Shultz, LD ;
Lansdorp, P ;
Dick, JE ;
Eaves, CJ .
BLOOD, 1997, 89 (12) :4307-4316
[8]   Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice [J].
Cashman, JD ;
Eaves, CJ .
BLOOD, 1999, 93 (02) :481-487
[9]   Expansion of blood CD34+ cells: Committed precursor expansion does not affect immature hematopoietic progenitors [J].
David, S ;
Boiron, JM ;
Dupouy, M ;
Rice, A ;
Vianes, I ;
Duperray, V ;
Reiffers, J .
JOURNAL OF HEMATOTHERAPY, 1997, 6 (02) :151-158
[10]  
Gluckman E, 1999, Cancer Treat Res, V101, P79